The group’s principle activities include developing, manufacturing and marketing biopharmaceutical products for treatments on cancer, inflammation and neurodegenerative disease. The group provides clinical programs, preclinical programs, and discovery programs. The group operates from United States.
Executive Information
Name
Title
Email
Warren Huff
CEO, Pres.
N/A
Paul Foster
Chief Medical Officer, VP - Clinical, Regulatory Affairs
